Protagonist Therapeutics Inc
PTGX
Equity
ISIN null / Valor 33278818
NASDAQ (2026-10-07)
USD 140.92+1.61%
Protagonist Therapeutics Inc
UMushroom community rating:
About company
Protagonist Therapeutics Inc is a biopharmaceutical company focused on discovering and developing peptide-based therapeutics to address unmet medical needs.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
115%1Y
768%3Y
678%5Y
Performance
48.2%1Y
52.1%3Y
74.1%5Y
Volatility
9119 M
Market cap (USD)
927,270
Daily traded volume (Shares)
38.82 / 38.16
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
4.00
Innovation:
3.33
Society:
4.00
Nature:
3.33
YUM K
Good
Ivan Bortolotti
Average
Liam Hawkeswood
🫵
EQUITIES OF THE SAME SECTOR
